However, GSK-3 is overexpressed in various cancer conditions such as colon, liver, ovarian, and pancreatic tumors and GSK-3β downregulation inhibits pancreatic cancer growth, angiogenesis, and vascular endothelial growth factor expression [29–32]. This evidence concerns the gene GSK3B and familial pancreatic carcinoma.